Accessibility Menu
Coloplast A/s logo

Coloplast A/s(OTC) CLPBY

Current Price$6.19
Market Cap$12.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)+8%
5 Year-60%
1 Year-34%
1 Month+7%
Coloplast A/s last closing stock price
MetricPriceDate
Last closeUSD 6.192026-07-24
Coloplast A/s stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-4.03%USD 6.452026-07-17
1 month+6.91%USD 5.792026-06-24
3 month-2.89%USD 6.372026-04-24
Year to date-26.31%USD 8.402025-12-31
1 year-33.65%USD 9.332025-07-24
3 year-44.56%USD 11.172023-07-25
5 year-59.97%USD 15.462021-07-23
Since inception+8.14%USD 5.722014-01-13

Coloplast A/s Financials at a Glance

Market Cap

$12.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

DKK 26.54B

Net Income (TTM)

DKK 2.07B

EPS (TTM)

$0.14

P/E Ratio

42.93

Dividend

$0.36

Beta (Volatility)

0.57 (Low)

Price

$6.19

Volume

402,673

Open

$6.11

Previous Close

$6.19

Daily Range

$6.10 - $6.19

52-Week Range

$5.64 - $10.03

Estimated Earnings Date

Aug 18, 2026

CLPBY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Coloplast A/s

Coloplast A/S, founded in 1954 and headquartered in Humlebæk, Denmark, is a global leader in intimate healthcare products and services. The company operates in three primary segments: Chronic Care, Interventional Urology, and Wound & Skin Care, serving a diverse international market.

Products and Services
  • Advanced ostomy solutions, including the SenSura Mio and Brava accessories
  • Continence care products like SpeediCath catheters and Conveen Active urine bags
  • Innovative wound dressings and a wide range of skin care items
Growth Outlook
  • Revenue of 7.2 billion DKK in Q2 2026, showing strong market demand
  • Operating income margin of 25.4% indicates efficient cost management
  • Continued investment in R&D to drive product innovation and market expansion
Financial Highlights
  • Trailing twelve month (TTM) revenue of 28.5 billion DKK reflects consistent growth
  • Net income margin of 7.5% demonstrates profitability despite market challenges
  • Dividend yield of 5.7% offers attractive returns to shareholders
Coloplast A/S has established itself as a significant player in the healthcare sector, focusing on innovative solutions for patients with chronic conditions. The company's commitment to research and development supports its growth strategy, ensuring a steady pipeline of new products. Recent financial performance indicates resilience, with a solid revenue base and profitability metrics that appeal to potential investors. The dividend yield further enhances the investment proposition, making Coloplast A/S a noteworthy consideration in the medical devices industry.
AI Generated • Jul 26, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

16,907

CEO

Lars Søren Rasmussen, MBA

Website

www.coloplast.com

Headquarters

Humlebæk, ZE 3050, DK

CLPBY Financials

Key Financial Metrics (TTM)

Gross Margin

58.60%

Operating Margin

26.47%

Net Income Margin

7.51%

Return on Equity

14.23%

Return on Capital

18.38%

Return on Assets

4.51%

Earnings Yield

2.33%

Dividend Yield

5.81%

Payout Ratio

2.46%

Stock Overview

Market Cap

$12.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

2.07B

Volume

402.67K

Avg. Volume

474.69K

Financials (TTM)

Gross Profit

DKK 17.24B

Operating Income

DKK 7.42B

EBITDA

DKK 11.88B

Operating Cash Flow

DKK 7.61B

Capital Expenditure

-DKK 1.57B

Free Cash Flow

DKK 6.04B

Cash & ST Invst.

DKK 1.07B

Total Debt

DKK 24.25B

Coloplast A/s Performance Analysis

Coloplast A/s annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30DKK 3,282,245,3135.2%
20232023-09-30DKK 3,507,139,8256.9%
20242024-09-30DKK 3,928,316,42412.0%
20252025-09-30DKK 4,124,716,4405.0%
Coloplast A/s sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-300.4%
Q42025-09-30-23.3%
Q12025-12-3131.9%
Q22026-03-312.3%
Coloplast A/s annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30DKK 0.32-11.6%
20232023-09-30DKK 0.32-1.2%
20242024-09-30DKK 0.332.8%
20252025-09-30DKK 0.24-26.9%
Coloplast A/s sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-06-30-11.9%
Q42025-09-308.4%
Q12025-12-3158.7%
Q22026-03-31-171.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

DKK 7.20B

+3.9%

Gross Profit

DKK 3.09B

-34.6%

Gross Margin

42.95%

N/A

Market Cap

$12.84BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$751.39K

N/A

Employees

17,083

N/A

Net Income

-DKK 987.14M

-208.2%

EBITDA

DKK 5.23B

+143.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

DKK 1.07B

+46.5%

Total Debt

DKK 24.25B

-0.0%

Accounts Receivable

DKK 4.98B

-9.3%

Inventory

DKK 3.95B

+3.9%

Long Term Debt

DKK 22.02B

+27.1%

Short Term Debt

DKK 2.23B

-67.8%

Return on Assets

4.51%

N/A

Return on Invested Capital

18.25%

N/A

Free Cash Flow

DKK 1.07B

+148.8%

Operating Cash Flow

DKK 1.48B

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SBHMYSino Biopharmaceutical Limited
$12.68+0.00%
SUVPFSartorius AG
$256.25+0.00%
SAUHYStraumann Holding AG
$11.64-1.02%
SDMHFSartorius Stedim Biotech S.A.
$193.00+0.52%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
TAT&T
$24.13+0.05%

Questions About CLPBY

What is the current price of Coloplast A/s?

Coloplast A/s is trading at $6.19 per share.

What is the 52-week range for Coloplast A/s?

Over the past 52 weeks, Coloplast A/s has traded between $5.64 and $10.03.

How much debt does Coloplast A/s have?

As of the most recent reporting period, Coloplast A/s reported total debt of DKK 3.74B.

How much cash does Coloplast A/s have on hand?

Coloplast A/s reported DKK 164.52M in cash and cash equivalents in its most recent financial results.

What is Coloplast A/s’s dividend yield?

Coloplast A/s currently has a dividend yield of 5.81%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services